Clinical Trials Browser

Phase 1 × Interventional × Mesothelin-positive Advanced Malignant Solid Tumors × Clear all

NCT05848999 2023-05-12

UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Mesothelin-positive Advanced Malignant Solid Tumors